Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer

Structural and Kinetic Characterization of Human Deoxycytidine Kinase Variants Able To Phosphorylate 5-Substituted Deoxycytidine and Thymidine Analogues,

(2010) Saugata Hazra et al.   BIOCHEMISTRY

A New Pyrimidine-Specific Reporter Gene: A Mutated Human Deoxycytidine Kinase Suitable for PET During Treatment with Acycloguanosine-Based Cytotoxic Drugs

(2010) Y. Likar et al.   JOURNAL OF NUCLEAR MEDICINE

Gene therapy for high-grade glioma

(2010) Atsushi Natsume et al.   Cell Adhesion & Migration

In Vitro Chemoresistance Testing in Well-Differentiated Carcinoid Tumors

(2009) John M. Lyons et al.   ANNALS OF SURGICAL ONCOLOGY

Extending Thymidine Kinase Activity to the Catalytic Repertoire of Human Deoxycytidine Kinase†‡

(2009) Saugata Hazra et al.   BIOCHEMISTRY

Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo

(2009) A Ardiani et al.   CANCER GENE THERAPY

Mimicking phosphorylation of Ser-74 on human deoxycytidine kinase selectively increases catalytic activity for dC and dC analogues

(2008) Theresa McSorley et al.   FEBS LETTERS